Colin Lee Novick (@cnovick1981) header
Colin Lee Novick (@cnovick1981) profile picture
品川区南品川
Joined January 2010
Photo by Colin Lee Novick (@cnovick1981)Photo by Colin Lee Novick (@cnovick1981)Photo by Colin Lee Novick (@cnovick1981)
Ian Novick completed the IRONMAN® Cozumel! Time 10:59:35, Run 04:55:25. (UNOFFICIAL) track.rtrt.me/e/IRM-COZUMEL-… #IMCozumel
1
1
Our team just applied to Startup World Cup @SWC2022 #innovacell #StartupWorldCup
2
Colin Lee Novick retweeted
Replying to @cnovick1981
@cnovick1981 also featured a great article in the latest AusBiotech Journal: ow.ly/d/6WPx
1
3
Apparently my account was hacked by a rather risque (and probably illegal) service provider. Apologies for the inconvenience.
1
A fun little article that sites findings in the Tufts CSDD Impact Report for Regenerative Medicine lnkd.in/e2CRSnv
1
Ono Pharmaceutical licenses Celyad's allogeneic NKR-2 immunotherapy for upfront payment of 1.25b JPY! More Japan!! lnkd.in/dFpCuuE
1
2
#sunset at #yokosuka Stn. I never knew that the support rails were from the #meijiera (1868 -… instagram.com/p/BHrZpu-h--m/ – at Yokosuka-shi, Kanagawa
1
Takenaka Corporation opened a new Bio Research Center that has a RegenMed CPC for biotechs looking to advance R&D! lnkd.in/edApe7e
1
Takeda Pharmaceuticals and TiGenix enter Ex-US Licensing Agreement for Cx601 with 25mEUR upfront payment! lnkd.in/enyDpxa
1
2
Sosei launches an 8yr, 2 billion JPY fund called "RMF1" for investment into Japanese regenerative medicine firms lnkd.in/e2nWNde
2
Adv Ctr for Tissue Eng (ACTE) to provide Daiichi Sankyo, with dental pulp cells and conduct collaborative research lnkd.in/er6RCGe
1
1
Japan's MHLW to ease the number of steps needed for starting recombinant microorganism (or virus) clinical trials lnkd.in/eKEi_cY
1
1
A brief yet informative piece on the question "why Japan?" for pharmaceutical development by PAREXEL. lnkd.in/eidFqcR
Cytori OA cell therapy approved under Japan's ASRM (not PMD Act conditional approval as article title suggests) lnkd.in/eSNURKT
TEMCELL used in 16 patients since release in FEB 2016. That's circa 216m JPY (2m USD) in sales in 4~5 mths. lnkd.in/dpgwjN7
RepliCel's (and Shiseido's) RCH-01 treatment or androgenic alopecia (AGA) featured in a Weekly Diamond article! lnkd.in/eN_ZmY7